| Pharmaceutical active ingredients: |
| CodeineErysimum Fluid Extract |
| Available forms, composition and doses of Polery Adultes: |
| Syrup; Oral; Codeine 11.8 mg; Erysimum Fluid Extract 443 mg / 5 ml |
| Polery Adultes medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N02AA59 - Codeine, combinations excluding psycholeptics |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Pierre Fabre |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Codelasa | Codeine; Ephedrine Hydrochloride; Sulfogaiacol | Ipsen Pharma |
| Expectofar | Codeine; Ephedrine; Mepiraxamine; Vitamin C | Esfar Laboratorios |
| Prontal | Codeine; Ephedrine; Salicylamide; Terpin | Robapharm |
| Euphon Capsules | Codeine; Erysimum dry extract | Mayoly Spindler Laboratoires; Jaba Farmaceutica |
| Euphon Syrup | Codeine; Erysimum dry extract | Mayoly Spindler Laboratoires; Jaba Farmaceutica |
| Polery | Codeine; Erysimum Fluid Extract; Pholcodine | Pierre Fabre |
| Tussipax Solution | Codeine; Ethylmorphine Hydrochloride | Bailleul Laboratoires |
| Tussipax Tablets | Codeine; Ethylmorphine Hydrochloride | Bailleul Laboratoires |
| Tussipax a l'Euquinine | Codeine; Ethylmorphine Hydrochloride; Eucalyptus Oil; Pine Oil; Quinine Etabonate | Bailleul Laboratoires |
| Tussipax | Codeine; Ethylmorphine Hydrochloride; Pectoral Species Concentrated | Bailleul Laboratoires |